78 / 78
PHARMA DYNAMICS CLOPIDOGREL 75 mg.
Each tablet contains 75 mg clopidogrel. S3 A42/8.2/0128. NAM NS2 10/7.1/0377. For full prescribing information, refer to the package insert approved by the Medicines Control Council,
October 2008.
1)
Database of Medicine Prices (14 March 2017). Department of Health website.
http://www.mpr.gov.za- Accessed on 30 March 2017.
2)
Poponina TM,
et al.
Current approaches to the prevention of thrombotic
complications in patients with acute coronary syndrome without ST-segment elevation. Topical issues of heart and vascular diseases. 2009;4:4-9. (English translation)
3)
Creager MA. Results of the CAPRIE trial: efficacy and
safety of clopidogrel. Vascular Medicine 1998;3:257-260.
4)
COMMIT Collaborative Group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. The Lancet
2005;366(9497):1607-1621.
5)
Sabatine MS,
et al.
Addition of Clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New England Journal of Medicine 2005;352:1179-89.
6)
The CURE Trial
Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine 2001;345:494-502.
PDCLD395/04/2017.
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Tel
021 707 7000
Fax
021 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762)
www.pharmadynamics.co.zaShown to reduce the risk of atherosclerotic events
in a wide range of patients with a history of:
•
Stroke
3,4,6
•
PAD
3
•
STEMI
4,5
•
Unstable Angina/NSTEMI
6
cost e ective
1
,
clinically proven
2
reduction
of atherosclerotic events